Lipocine Inc. (LPCN) stock
LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)
Close on Nov 17, 2026Market cap $13.19MP/E –Yield –
Lipocine operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lipocine's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.19M. For fiscal 2025 it was -$9.76M. The highest annual figure on record is -$7.30K in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.76M | – |
| FY2024 | Dec 31, 2024 | -$1.22M | – |
| FY2023 | Dec 31, 2023 | -$11.87M | – |
| FY2022 | Dec 31, 2022 | -$11.97M | – |
| FY2021 | Dec 31, 2021 | -$4.41M | – |
| FY2020 | Dec 31, 2020 | -$15.30M | – |
| FY2019 | Dec 31, 2019 | -$11.67M | – |
| FY2018 | Dec 31, 2018 | -$12.08M | – |
| FY2017 | Dec 31, 2017 | -$16.70M | – |
| FY2016 | Dec 31, 2016 | -$18.28M | – |
| FY2015 | Dec 31, 2015 | -$15.36M | – |
| FY2014 | Dec 31, 2014 | -$17.30M | – |
| FY2013 | Dec 31, 2013 | -$8.59M | – |
| FY2012 | Dec 31, 2012 | -$3.18M | – |
| FY2011 | Dec 31, 2011 | -$7.30K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.03M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.26M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.92M | -271.5% |
| Q3 FY2025 | Sep 30, 2025 | -$2.99M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.97M | -181.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.83M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.50M | – |
| Q1 FY2024 | Mar 31, 2024 | $2.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.02M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.61M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.31M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.93M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.84M | -120.4% |
| Q3 FY2022 | Sep 30, 2022 | -$3.20M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.05M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.89M | – |
| Q4 FY2021 | Dec 31, 2021 | $8.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.06M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.68M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.38M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.31M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.80M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.56M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.00M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.23M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.36M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.74M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.75M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.30M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.57M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.70M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.14M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.55M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.05M | – |
See a number that looks wrong?